Elimination Kinetics of Terbinafine from Human Plasma and Tissues following Multiple-Dose Administration, and Comparison with 3 Main Metabolites
- 26 October 1994
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 8 (4) , 203-210
- https://doi.org/10.1007/bf03258479
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 daysClinical and Experimental Dermatology, 1994
- Short term treatment of dermatophyte onychomycosis with terbinafine.BMJ, 1992
- Pharmacokinetics of terbinafine in the nailBritish Journal of Dermatology, 1992
- Dose-proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteersBritish Journal of Dermatology, 1992
- Allylamine Antifungal DrugsPublished by Springer Nature ,1992
- Pharmacokinetics of Lamisil® in humansJournal of Dermatological Treatment, 1990
- In vitro activity of terbinafineClinical and Experimental Dermatology, 1989
- Clinical pharmacokinetics of terbinafine (Lamisil)Clinical and Experimental Dermatology, 1989
- Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infectionsAntimicrobial Agents and Chemotherapy, 1985
- Allylamine Derivatives: New Class of Synthetic Antifungal Agents Inhibiting Fungal Squalene EpoxidaseScience, 1984